Actively Recruiting
EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA
Led by Celal Bayar University · Updated on 2025-02-27
48
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Placenta previa can cause a risk of severe bleeding during labor. Placenta previa is usually classified into four different types: total, partial, marginal and asymptomatic. The condition is diagnosed by ultrasonography later in pregnancy and its management varies depending on the location of the placenta and the presence of bleeding. Studies show that the increased frequency of placenta previa is associated with increased cesarean section rates and maternal age (1). Furthermore, the effects of placenta previa on maternal and fetal morbidity can be reduced with proper management (2). Placenta percreata is a condition in which the placenta invades the myometrium (uterine muscle) and serosa (outer surface of the uterus). This can make postpartum detachment of the placenta difficult, leading to severe bleeding and complications. Placenta perforata is often associated with placenta previa and may require surgical intervention. Ultrasonography and magnetic resonance imaging (MRI) are used to diagnose this condition. Risk factors include previous cesarean deliveries and placenta previa (3). Placenta percreata requires careful management as it increases the risk of maternal mortality and morbidity (4). In this study, we aimed to investigate the levels of decorin, laminin, collagen-1, TGFβ-1, PDGF in placentas of pregnant women with placenta percreata and previa.
CONDITIONS
Official Title
EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy pregnancy under 37 weeks
- Age between 18 and 50 years
- Ability to read and understand Turkish
- No additional diseases
- Agreeing to participate in the study
You will not qualify if you...
- High-risk pregnancies such as gestational hypertension, preeclampsia, HELLP syndrome, chronic hypertension, gestational or pregestational diabetes, cholestasis, or intrauterine growth retardation
- Multiple pregnancy
- Pregnancy under 18 years of age
- Smoking
- Use of medications other than routine pregnancy supplements
- Presence of additional diseases including thyroid disorders, kidney or liver failure, hepatitis, heart disease, or connective tissue diseases
- Use of immunosuppressive drugs
- Active or chronic infections
- Active or chronic inflammatory diseases
- Giving birth at an external center or later withdrawal from the study
- Development of exclusion criteria after initial inclusion
- Premature birth in control group participants
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Manisa Celal Bayar University
Manisa, Turkey (Türkiye)
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here